首页> 外国专利> NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DISEASE CAUSED BY INFLUENZA VIRUS INFECTION

NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DISEASE CAUSED BY INFLUENZA VIRUS INFECTION

机译:新型化合物或药学上可接受的盐及其组成与预防或治疗由流感病毒感染引起的疾病的活性成分相同的药物成分

摘要

The present invention relates to a novel compound or pharmaceutically acceptable salt thereof, and to a pharmaceutical composition containing the same as an active ingredient for treating and preventing disease caused by influenza virus infection. The novel compound represented by chemical formula 1 according to the present invention not only has extremely excellent antivirus activity, but also has less side effects for a human body by not having cytotoxicity for a human cell. Therefore, a pharmaceutical composition containing the same as an active ingredient can be used in preventing or treating such as flu, colds, sore throats, bronchitis, pneumonia, bird flu, swine flu, and goat flu caused by influenza virus infection.;COPYRIGHT KIPO 2015
机译:本发明涉及一种新颖的化合物或其药学上可接受的盐,以及涉及包含该化合物的药物组合物作为用于治疗和预防由流感病毒感染引起的疾病的活性成分。根据本发明的由化学式1表示的新型化合物不仅具有极好的抗病毒活性,而且由于对人体细胞没有细胞毒性,因此对人体的副作用也较小。因此,含有作为有效成分的药物组合物可用于预防或治疗由流感病毒感染引起的流感,感冒,喉咙痛,支气管炎,肺炎,禽流感,猪流感和山羊流感等。 2015年

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号